International leadership

Advisor of Pavillon Capital (Temasek) for healthcare investments in Asia.
Executive with 30+ years of experience in the pharmaceutical and healthcare industry in several roles, including President of APAC of IMS Health, CEO of Agenix Limited, General Manager of Wellcome Singapore, Head of Asia Pacific of Covance, General Manager of Parkway Group Hospitals

Former Director, Industry and Business Development Department, the Singapore Immunology Network (SIgN), A*STAR.
Founder of Biopolo scrl, dedicated to the development of Biotech Industry in Italy.
Joined Biomarkers in 2015 as CEO

Founder and former Scientific Director of the Singapore Immunology Network (SIgN). EMBO member, Marie Curie Chair at the Institute Pasteur.
Former Professor of Immunology at the Universities of Singapore NUS and NTU, and former Chair of Immunology and General Pathology at the University of Milano Bicocca.

Board-certified physician-scientist in medical genetics, obgyn, and maternal-fetal medicine. Chief Medical Officer and Former VP of Clinical Development and Medical Affairs at Ariosa Diagnostics, then Roche. Former Director of Clinical Affairs at Novartis Diagnostics.
Former faculty member at the University of California.

Former R&D Director at Toma Lab, Chair of the Technologies in Reproductive Screening and Diagnosis SIG at the International Society for Prenatal Diagnosis and therapy (ISPD) and member of the editorial board of Prenatal Diagnosis journal. Contract Professor at the Medical Genetics Specialty School of the University of Milan

Coordinator of operations and R&D activities in Italy and Singapore.
Joined Menarini Silicon Biosystems’ R&D team in 2010, and developed a solid background on rare and single cells analysis.
Joined Biomarkers in 2014 to lead a research project focusing on the discovery of novel biomarkers for the isolation of fetal cells.